Results 1 to 10 of about 1,068 (108)

Characterization and comparation of toxicity between natural realgar and artificially optimized realgar [PDF]

open access: yesFrontiers in Pharmacology
ObjectiveRealgar possesses important medical properties. This article aims to evaluate realgar and emerging artificially optimized realgar to ensure safe clinical use.MethodsMultiple techniques were employed to test natural realgar and artificially ...
Lu Luo, Qiaochu Wang, Shuangrong Gao
exaly   +4 more sources

Traditional mineral medicine realgar and Realgar-Indigo naturalis formula potentially exerted therapeutic effects by altering the gut microbiota [PDF]

open access: yesFrontiers in Microbiology, 2023
IntroductionRealgar has a long history ofuse in traditional medicines. However, the mechanism through which Realgar or Realgar-Indigo naturalis formula (RIF) exert therapeutic effects is only partially understood.MethodsIn this study, 60 feces and 60 ...
Qiaochu Wang, Ziwen Xu, Wang Qiaochu
exaly   +4 more sources

Realgar‐Induced CNS Toxicity: Exploring OTC‐Mediated Ornithine Regulation of ZBTB7A Inhibits Astrocyte Glycolysis Based on the Liver–Brain Axis [PDF]

open access: yesAdvanced Science
Realgar, an arsenic‐containing traditional Chinese medicine, is commonly used in clinical practice. However, prolonged, excessive, or uncontrolled administration of Chinese patent medicines containing realgar can occasionally induce adverse effects ...
Ping Ye   +7 more
doaj   +2 more sources

A Metabolic Profiling Study of Realgar-Induced Acute Kidney Injury in Mice

open access: yesFrontiers in Pharmacology, 2021
Realgar has been used as a type of mineral drug that contains arsenic for thousands of years. Previous studies have shown that Realgar-induced acute kidney injury is associated with abnormal metabolism, but the underlying mechanism is poorly understood ...
Heng Zhou, Limin Li, Shen Ji
exaly   +3 more sources

Fast pH‐Driven Solubilization Method of Realgar (As4S4) to Reduce the Toxicity of Arsenic [As(III)] for Medicinal Purposes [PDF]

open access: yesAdvanced Science
Acute promyelocytic leukemia (APL) accounts for 5–15% of acute myeloid leukemia cases. It is typically characterized by the (15;17) chromosomal translocation, producing the pathogenic retinoic acid receptor (RAR) alpha/promyelocytic leukemia (PML) fusion
Bojana Lucic   +20 more
doaj   +2 more sources

Single-cell transcriptome sequencing reveals the mechanism of Realgar improvement on erythropoiesis in mice with myelodysplastic syndrome [PDF]

open access: yesCancer Cell International
Myelodysplastic syndrome (MDS) is a malignant hematologic disorder with limited curative options, primarily reliant on hematopoietic stem cell transplantation. Anemia, a prevalent symptom of MDS, has few effective treatment strategies.
Hao Xu   +9 more
doaj   +2 more sources

The regulatory effects of realgar and cinnabar on glucose metabolism in mice [PDF]

open access: yesFrontiers in Endocrinology
BackgroundGlucose metabolism plays a central role in maintaining systemic energy homeostasis, and its dysregulation is closely linked to the pathogenesis of metabolic diseases such as diabetes mellitus. While traditional mineral medicines such as realgar
Yifan Zhang   +9 more
doaj   +2 more sources

Research progress on arsenic, arsenic-containing medicinal materials, and arsenic-containing preparations: clinical application, pharmacological effects, and toxicity [PDF]

open access: yesFrontiers in Pharmacology
Introduction: The toxicity of arsenic is widely recognized globally, mainly harming human health by polluting water, soil, and food. However, its formulations can also be used for the clinical treatment of diseases such as leukemia and tumors.
Yichu Yang   +7 more
doaj   +2 more sources

Realgar toxicity in terms of its chemical characterization, pharmacological mechanisms, and metabolic profile: A review

open access: yesScience of Traditional Chinese Medicine, 2023
. Realgar is an arsenic-containing Chinese medicine known for its toxin-removing, phlegm-dispelling, and malaria-intercepting effects. It has proven to be effective in the treatment of acute promyelocytic leukemia.
Yan Yi   +3 more
doaj   +1 more source

Xanthine oxidase, a therapeutic target of realgar for non-small cell lung cancer

open access: yesHeliyon, 2023
Background: The effects of realgar against non-small cell lung cancer (NSCLC) have been massively studied, but the direct therapeutic targets of realgar remain unclear.
Rui Guo   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy